Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Journal of Hepatology
|
December 16, 2014
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients
Hai Feng, Zhuo Yu, Yuan Tian, et al.
The Journal of Urology
|
April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter
Franklin D Gaylis, Matthew R Cooperberg, Ronald C Chen, et al.
British Journal of Cancer
|
March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
S C C Wong, S S M Ng, M T Cheung, et al.
The Journal of Urology
|
November 13, 2004
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment
Peter R Carroll, June M L Chan, Anthony V D'Amico, et al.
Cancer Cell
|
March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma
W K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
JHEP Reports : Innovation in Hepatology
|
January 26, 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)
Grainne M O'Kane, Aruz Mesci, Raymond W Jang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Cancer
|
May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
Edwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2023
Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches
Pei-Jen Lou, W K Jacky Lam, Wan-Lun Hsu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Journal of Hepatology
|
December 16, 2014
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients
Hai Feng, Zhuo Yu, Yuan Tian, et al.
The Journal of Urology
|
April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter
Franklin D Gaylis, Matthew R Cooperberg, Ronald C Chen, et al.
British Journal of Cancer
|
March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
S C C Wong, S S M Ng, M T Cheung, et al.
The Journal of Urology
|
November 13, 2004
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment
Peter R Carroll, June M L Chan, Anthony V D'Amico, et al.
Cancer Cell
|
March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma
W K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
JHEP Reports : Innovation in Hepatology
|
January 26, 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)
Grainne M O'Kane, Aruz Mesci, Raymond W Jang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Cancer
|
May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
Edwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2023
Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches
Pei-Jen Lou, W K Jacky Lam, Wan-Lun Hsu, et al.
Page
of 7